ライフサイエンスコーパス: octapeptide

1 peroxynitrite formation in response to this octapeptide.

2 T lymphocytes (CTL) to the fusion partner's octapeptide.

3 a transcription repression domain called the octapeptide.

4 ch contributes to hypertension caused by the octapeptide.

5 ased contractile response to cholecystokinin octapeptide.

6 o generate dose-response curves for the free octapeptide.

7 ion 4 in beta-sheet A of this serpin with an octapeptide.

8 Ki = 0.40 +/- 0.03 microM) than the starting octapeptide.

9 n Pax-B, having both the homeodomain and the octapeptide.

10 the self-assembly of lanreotide, a cationic octapeptide.

11 contain a paired-type homeodomain and/or an octapeptide.

12 roduct was identified as the SLVELTSL (SEL8) octapeptide.

13 s, ursodeoxycholic acid, and cholecystokinin-octapeptide.

14 rnifin beta contains 21 tandem repeats of an octapeptide.

15 ned with the upstream di-arginine-containing octapeptide.

16 (-1) for a small organic molecule and for an octapeptide.

17 hown to be the case in 18-membered ring SRIF octapeptides.

18 various cancers expressing receptors for SST octapeptides.

19 ins of eight saccharides cross-linked by two octapeptides.

20 et bind to two and only two groups of nRNP A octapeptides.

21 mushrooms in the genus Amanita, are bicyclic octapeptides.

22 (IC(50) = 2-4 nM) cyclic somatostatin (SRIF) octapeptides.

23 ravenous injection of either cholecystokinin octapeptide (200 mug/kg in 0.3 mL saline) or vehicle pla

24 ) selectivity, substitution of Trp(8) in the octapeptide 9 by imBzl-l- or -d-His(8) results in loss o

25 Octapeptide 9 was prepared by de novo synthesis using a

26 e obelin label in a controlled manner to the octapeptide, a fusion protein was produced using recombi

27 In contrast to virus bearing lysine octapeptide, Ad vector displaying a polylysine was capab

28 The 3D NMR structures of six octapeptide agonist analogues of somatostatin (SRIF) in

29 s NMT has been synthesized starting from the octapeptide ALYASKLS-NH2 (2).

30 4 microM) equivalent to that of the starting octapeptide, ALYASKLS-NH2.

31 The cyclic octapeptide amanitin is a relatively selective inhibitor

32 of poisonous Amanita mushrooms are bicyclic octapeptides (amatoxins) or heptapeptides (phallotoxins)

33 The cholecystokinin (26-33) [CCK (26-33)] octapeptide analog Asp-Tyr-D-Phe-Gly-Trp(N-Me)-Nle-Asp-P

34 though a number of synthetic hexapeptide and octapeptide analogs of SRIF bind selectively to SSTR2.

35 ethyl amino acid substitutions in a standard octapeptide analogue format.

36 e-dimensional NMR structures of eight cyclic octapeptide analogues of somatostatin (SRIF) are describ

37 ative L,5D6 antagonist motif on somatostatin octapeptide analogues with a cyclic hexapeptide core.

38 In addition, both lysine octapeptide and polylysine ligands were accessible for b

39 tic secretion in response to cholecystokinin octapeptide and reduced pancreatic digestive enzyme prot

40 as gastrin/carboxy-terminal cholecystokinin octapeptide and selective cholecystokinin antagonists, c

41 ess responsive to vesicular stomatitis virus octapeptide and unresponsive to weak peptide agonists, a

42 Due to the high specificity of the displayed octapeptides and avidity effect of their multicopy displ

43 synthesized a library of over half a million octapeptides and exposed it to light and air in pH 7.4 b

44 ginyl endopeptidase, we prepared a series of octapeptides and mutant legumin B and G4 glycinin subuni

45 -scanning studies with overlapping deca- and octapeptides and polygonal rabbit and human infant immun

46 se activity (using hydrolysis of a synthetic octapeptide), and MMP-8 (using a Western blot) and the b

47 (ELISA) screening against synthesized serial octapeptides, and ELISA screening, with anti-PM-Scl posi

48 Degradation of the biologically potent octapeptide angiotensin Ang II-(1-8) is mediated by the

49 The octapeptide angiotensin II (AII) is proteolytically proc

50 We have shown previously that the octapeptide angiotensin II (Ang II) activates the AT1 re

51 ic forms of ACE both generate the vasoactive octapeptide angiotensin II (Ang II) with equal efficienc

52 eave angiotensin I (Ang I) to the vasoactive octapeptide angiotensin II (Ang II), but is also able to

53 The octapeptide angiotensin II (AngII) exerts a variety of c

54 ngiotensin I to produce a potent vasopressor octapeptide, angiotensin II.

55 ntification of novel disulfide-linked cyclic octapeptide antagonists of somatostatin is described.

56 hin the MMTV env gene and was defined by the octapeptide ANYDFICV (AFV8).

57 as solubilized by adding the very polar FLAG octapeptide (Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys) to the N-t

58 of principle, we have appended an extraneous octapeptide at the N terminus of hepatitis B virus capsi

59 M were matched by incubating DC with cognate octapeptides at 1-10 pM, indicating that display of very

60 predicted to be essential for the binding of octapeptides based on the observation that SSTR1 can bin

61 We showed that cyclic synthetic octapeptides based on the sequence of this loop from Ago

62 Octapeptide binding complements the shape of the combini

63 entarity and greater number of contacts, the octapeptide binds with an affinity (KA = 2.5 x 10(5) M-1

64 After injection of cholecystokinin octapeptide, blood temperature decreased progressively f

65 H-2(b) mice specific for the VSV8 (RGYVYQGL) octapeptide bound to Kb, we identified a single weak ago

66 specific for the vesicular stomatitis virus octapeptide bound to the H-2K(b) molecule were compared

67 s high affinity for sulfated cholecystokinin octapeptide but has > or = 1000-fold lower affinity for

68 B contains a Pax2/5/8-type paired domain and octapeptide, but a Pax6 prd-type homeodomain.

69 The evolved octapeptides, but not first-generation peptides, discrim

70 Removal of the FLAG octapeptide by proteolysis with enterokinase converted t

71 ubicin (AN-201) linked covalently to the SST octapeptide carrier RC-121 (D-Phe-Cys-Tyr-D-Trp-Lys-Val-

72 n applied to the discovery of a new class of octapeptide catalysts for the kinetic resolution of seco

73 The sulfated octapeptide CCK-8S increased action potential frequency

74 for the ability of systemic cholecystokinin octapeptide (CCK) (0 or 10 microg/kg) to inhibit food in

75 Systemic administration of cholecystokinin octapeptide (CCK) slows gastric emptying, inhibits feedi

76 genic mice 5 min after 10 pM cholecystokinin octapeptide (CCK) stimulation was enhanced by 160% of co

77 2 mg/kg, i.p.), and sulfated cholecystokinin octapeptide (CCK-0.05 and 0.1 mg/kg, i.p.) were used to

78 Monoglycated cholecystokinin octapeptide (CCK-8) (glucitol-Asp1 adduct) modified at t

79 cular (i.c.v.) injections of cholecystokinin-octapeptide (CCK-8) and somatostatin (SST) and the inter

80 Cholecystokinin octapeptide (CCK-8) and substance P (SP) were used to ac

81 by a continuous intravenous cholecystokinin octapeptide (CCK-8) infusion was determined by ultrasono

82 The carboxy terminal octapeptide (CCK-8) is fully active in this regard, but

83 prostaglandin E2 (PGE2) and cholecystokinin octapeptide (CCK-8).

84 ts to pancreatitis caused by cholecystokinin octapeptide (CCK-8).

85 P1B3 specifically transports cholecystokinin octapeptide (CCK-8).

86 al injection of low doses of cholecystokinin octapeptide (CCK-8; 10-60 pmol); group B neurones respon

87 he density and distribution of sulphated CCK octapeptide (CCK8S) binding sites and preproCCK peptide

88 n (apo) B17, and various apoB-FLAG (DYKDDDDK octapeptide) chimeras to purified LPL.

89 Two targeted chromogenic octapeptide combinatorial libraries, comprised of 38 poo

90 Insertion of an octapeptide consisting of the P14-P7 residues of the rea

91 Synthesis of a corresponding octapeptide containing 5 of the 6 interacting residues g

92 le amino acid carriers and to tripeptides or octapeptides containing tyrosine or histidine as central

93 nexpected functional properties of 1 and the octapeptide cyclo(3-14)H-Cys-Phe-Phe-Trp(8)-Lys-Thr-Phe-

94 the PG monomer revealed that the ramoplanin octapeptide D-Hpg-D-Orn-D-alloThr-Hpg-D-Hpg-alloThr-Phe-

95 MSO-d6, 300 K) and molecular modeling of the octapeptide D-Phe1-Cys2-Phe3-D-Trp4-Lys5-Thr6-Cys7+ ++-T

96 An octapeptide derived from RANTES also exhibited neuroprot

97 MC-2, a synthetic octapeptide derived from the heparin-binding domain of m

98 hapten-modified peptides, the immunodominant octapeptide derived from vesicular stomatitis virus nucl

99 TyrBm oxidation of three tyrosine-containing octapeptides derived from glycinin was analyzed by oxyge

100 Among the native partners of PDZ10, octapeptides derived from the hc-kit and 5HT2c proteins

101 entally measured value 10.1 +/- 0.8% for the octapeptide des-Arg(1)-bradykinin.

102 helix with the additional involvement of the octapeptide domain and its N-terminal flanking amino aci

103 riant, c.547G>A (p.Gly183Ser), affecting the octapeptide domain of PAX5 that was found to segregate w

104 e COOH terminus and is down-modulated by the octapeptide element.

105 This octapeptide exerts diverse effects that include inductio

106 The two independent molecules of the octapeptide fold into almost ideal beta-hairpin conforma

107 the contractile response to cholecystokinin octapeptide for up to 96 hours after endotoxin administr

108 N15 TCR [1-4] and its peptide-MHC ligand, an octapeptide fragment representing amino acids 52-59 of t

109 Deletion of the N-terminal octapeptide from Mtb's alpha-chain led to disappearance

110 xyphenylalanine, is a potently antimicrobial octapeptide from the blood cells of the solitary tunicat

111 a share binding to eight antigenic groups of octapeptides from nRNP A.

112 und in a patient serum is bound to these two octapeptides from nRNP A.

113 This leader peptidase removes specific octapeptides from the amino terminus of nuclear-encoded

114 mma12 state I since in a shorter gamma-chain octapeptide, GAKQAGDV, gamma12-I is not observed.

115 An octapeptide (GLYASKLS-NH2) derived from a N-terminal Arf

116 a)-methylated aminoglycine (Agl) scan of the octapeptide H-c[Cys(3)-Phe(6)-Phe(7)-dTrp(8)-Lys(9)-Thr(

117 pseudobactins from P. fluorescens A225, the octapeptide has the sequence Chr-Ser(1)-Ala-AcOHOrn-Gly-

118 A (D-ala(1)-peptide T-amide, a gp120-derived octapeptide homologous to VIP) prevent neuronal cell dea

119 sidues in TM2 of the type 1 receptor for the octapeptide hormone angiotensin II.

120 +) release in response to angiotensin II, an octapeptide hormone that promotes cardiac hypertrophy.

121 Condensation of 10 with octapeptide ILGFVFTL (9) gave prodrug precursor 11b.

122 nous application of sulfated cholecystokinin octapeptide in a reversible and concentration-dependent

123 The amino acid sequence for the octapeptide in case of pseudobactins from P. putida ATCC

124 the contractile response to cholecystokinin octapeptide in gallbladder strips 4 hours after endotoxi

125 support has been used to synthesize tri- to octapeptides in 28 to 97% yields using only 1.2 equiv of

126 rions can be produced following insertion of octapeptides in the two C-terminal turns of H2.

127 MN10021 and derived octapeptides induce iNOS (inducible nitric oxide synthas

128 rdiopulmonary resuscitation, cholecystokinin octapeptide induced mild hypothermia, attenuated postres

129 -free liposomes for 4 hours, cholecystokinin octapeptide-induced contraction, membrane cholesterol co

130 Beginning with a weak octapeptide inhibitor ALYASKLS-NH2 (2, Ki = 15.3 +/- 6.4

131 hamster ovary cells with an immunodetectable octapeptide inserted at their amino-terminal ends.

132 ce express a prion protein (PrP) with a nine-octapeptide insertion associated with a human familial p

133 sed Tg(PG14) mice, which express PrP with an octapeptide insertion associated with an inherited prion

134 olog of a mutant human PrP containing a nine octapeptide insertion associated with prion dementia.

135 ansgenic mice express PrP that harbor a nine-octapeptide insertional mutation homologous to one descr

136 monstrate that the incorporation of the FLAG octapeptide into the HI loop does not ablate fiber trime

137 d PA225-I, II), the serine(1) residue of the octapeptide is attached to the carboxylic acid group on

138 H3K79 methyltransferase, interacts with the octapeptide/leucine zipper domain of AF10, and this regi

139 substrate specificity using tetrapeptide and octapeptide libraries in a positional scanning format, e

140 On-bead screening of an octapeptide library (theoretical diversity of 160 000) i

141 ently revised receptor-bound model for CCK-B octapeptide ligands and are in good agreement with the D

142 eptin docking site was mapped to a divergent octapeptide loop in the AGR2 superfamily between amino a

143 r the suggestion that the Cys-110 to Cys-117 octapeptide loop of human AGRP mimics the conformation o

144 rangement of the disulfide bonds predicts an octapeptide loop, and the chemical properties of four re

145 rotein that contains the naturally processed octapeptide LTFNYRNL (LYL8) presented by the Kb MHC mole

146 An octapeptide (m/z - 902.51, IQKVAGTW) synthesized was fou

147 The octapeptide-mediated repression is also seen within a he

148 e of the pathogen Shigella flexneri Y and an octapeptide (Met-Asp-Trp-Asn-Met-His-Ala-Ala), a functio

149 We constructed an octapeptide mimicking the omega loop and found that it s

150 ng PEPSCAN each mAb reacted with a number of octapeptides, most of which were derived from within the

151 he homeo-, OAR, and Rx domains, but lacks an octapeptide motif.

152 and vesicular stomatitis virus nucleoprotein octapeptide N52-59 relevant for the lymphocytic choriome

153 itioning of ions into a self-assembled (D,L)-octapeptide nanotube, cyclo[-(L-Ala-D-Ala)(4)-], are pre

154 The central nervous system octapeptide, neuropeptide FF (NPFF), is believed to play

155 The octapeptide-obelin fusion protein retained the biolumine

156 Infusion of a subthreshold dose of the octapeptide of CCK (15 pmol (kg body wt)-1 h-1) potentia

157 nderwent quantitative cholescintigraphy with octapeptide of CCK (CCK-8).

158 9), and its interactions with the C-terminal octapeptide of cholecystokinin (CCK-8) have been determi

159 his study was undertaken to test whether the octapeptide of cholecystokinin (regular CCK-8) and pharm

160 The bimolecular complex of the C-terminal octapeptide of cholecystokinin, CCK-8, with the N-termin

161 The interaction of the C-terminal octapeptide of cholecystokinin, CCK-8, with the third ex

162 d heptapeptide (called CyRP-71) and a linear octapeptide of sequence RRNYRRNY.

163 EBNA-1 and the maximally overlapping unique octapeptides of EBNA-1 were tested by modified ELISAs.

164 receptor C-terminal sequence, as well as for octapeptides of eight other putative partner proteins of

165 uated the binding of lupus autoantibodies to octapeptides of nuclear ribonucleoprotein (nRNP) A, iden

166 sera by solid-phase scanning of overlapping octapeptides of variable domains (VDs) of the major oute

167 predominant that was converted to the final octapeptide only in presence of the appropriate MHC I mo

168 P is observed in the presence of either FLAG octapeptide or bovine serum albumin.

169 th to determine responses to cholecystokinin octapeptide or electrical field stimulation.

170 monitoring the generation of an OVA-derived octapeptide, OVA257-264 (SL8), and its C-terminally exte

171 portion a nuclear localization signal and an octapeptide (PPPRMPPP) with similarity to a major B cell

172 p beta C8Ala, AspCD2Ala) mutant bound to the octapeptide PQpYEEIPI (where pY indicates a phosphotyros

173 molecules that mimic this epsilonPKC agonist octapeptide provide a powerful therapeutic approach to p

174 we describe an epsilonPKC-selective agonist octapeptide, psiepsilon receptor for activated C-kinase

175 ensus epitope via in vitro evolution yielded octapeptides QPEQAFPE and PFPEQxFP that identified omega

176 d in protegrins and tachyplesins whereas the octapeptide R8 (RLYRKVYG) consists of an R4 and a degene

177 to eight copies of a tetrapeptide (R4) or an octapeptide (R8).

178 otoxic hybrid analogs of somatostatin (SST), octapeptides RC-160 (D-Phe-Cys-Tyr-D-Trp- Lys-Val-Cys-Tr

179 is experiments, confirmed the presence of an octapeptide receptor-binding domain toward the amino ter

180 d-type affinity for sulfated cholecystokinin octapeptide, receptors with increasing amino-terminal co

181 rion disease caused by a prion protein (PrP) octapeptide repeat insertion mutation originates from so

182 tations P102L, D178N, E200K and 2-, 4- and 6-octapeptide repeat insertions) and show that the glycofo

183 to bind to the protein in a highly conserved octapeptide repeat region (sequence PHGGGWGQ) near the N

184 Deletion of the octapeptide repeat region did not affect the rescuing ac

185 The copper-binding octapeptide repeat region of PrP was involved in the eff

186 nic strength, confirming that the N-terminal octapeptide repeat region of PrPSc is not required for b

187 Both the KKRPK motif and the octapeptide repeat region of rPrP are essential for maxi

188 ing sites are localized predominantly in the octapeptide repeat region, whereas sites that bind both

189 containing residues 91-231, which lacks the octapeptide repeat region.

190 ationally masked epitopes in the central and octapeptide repeat regions.

191 ecules expressing 7, 9, and 11 copies of the octapeptide repeat sequence showed altered cell surface

192 rion-related peptides differing in number of octapeptide repeat units (PHGGGWGQ), (PHGGGWGQ)(2), and

193 (IPD) include an insertion of six additional octapeptide repeats (6-OPRI) and a missense mutation (P1

194 on-protein-mediated zinc influx requires the octapeptide repeats and amino-terminal polybasic region

195 other carries an insertion of six additional octapeptide repeats between codons 51 and 90.

196 und that only a mutant containing nine extra octapeptide repeats failed to suppress Bax-induced cell

197 insertion mutant (10OR) with five additional octapeptide repeats linked to familial CJD.

198 res the presence of at least one of the five octapeptide repeats normally present in the N-terminal h

199 oma cells, hamster PrP-sen with 5, 9, and 11 octapeptide repeats were expressed normally on the cell

200 e, hamster PrP molecules with greater than 7 octapeptide repeats were more aggregated and more protea

201 s a mutant prion protein (PrP) containing 14 octapeptide repeats whose human homologue is associated

202 express a pathogenic mutant with nine extra octapeptide repeats, also binds more strongly to GAG tha

203 other insertion mutant, which has five extra octapeptide repeats, rPrP(10OR).

204 uman prion protein that has three additional octapeptide repeats, rPrP(8OR).

205 tion of patients from the UK with four extra octapeptide repeats, which suggest that the risk of clin

206 ich encodes an expanded PrP with eight extra octapeptide repeats.

207 oeba histolytica antigens containing 2 to 16 octapeptide repeats.

208 binding of PTIP to Pax2 is inhibited by the octapeptide repression domain.

209 The linear sequences (through common octapeptide-resin intermediates) were assembled smoothly

210 The vesicular stomatitis virus (VSV) octapeptide RGYVYQGL binds to H-2K(b) and triggers a cyt

211 ted CTLs specific for the immunodominant VSV octapeptide RGYVYQGL.

212 Conjugate 5, which features an octapeptide segment attached by an ester linkage at the

213 In the octapeptide segment IFGSFFTL in IIIS6 of a cockroach sod

214 lving imidazoles from histidines in adjacent octapeptide segments.

215 ngly, the deduced BGAF sequence contained an octapeptide sequence (G(P/R)WGGSGG) repeated twice.

216 We conclude that the octapeptide sequence and neighboring amino acids in the

217 use treatment of patients with peptide T (an octapeptide sequence found in the human immunodeficiency

218 We found that SIAH1 bound to an octapeptide sequence in T-STAR targeting it for proteaso

219 Mutation or deletion of the conserved octapeptide sequence results in increased transactivatio

220 ) contains four copies of a highly conserved octapeptide sequence, PHGGGWGQ, that is flanked by two p

221 different amino acids in a highly-conserved octapeptide sequence, Z8, located within the region remo

222 predicted to contain two PAAP collagen-like octapeptide sequences.

223 confers a conjugative mating response to an octapeptide sex pheromone (cAD1) secreted by plasmid-fre

224 a mating response induced by exposure to an octapeptide sex pheromone, cAD1, secreted by plasmid-fre

225 The alpha/beta-octapeptides showed the presence of HTH structures with

226 r a series of tripeptides and for two larger octapeptides, showing that the diagnostic phosphate OH s

227 ith the complex of H-2K(b) and the ovalbumin octapeptide SIINFEKL) and peptide-pulsed APCs.

228 65), fused to a polypeptide that contains an octapeptide (SIYRYYGL) agonist for a particular T cell r

229 d on the observation that SSTR1 can bind the octapeptide SMS-201-995 with reasonable affinity after a

230 i-PMScl positive sera did not react with any octapeptide spanning the major epitope area (aa 207-246)

231 on of a mass-labeled leucine monomer from an octapeptide spiked standard was employed as a measure of

232 of 2-pyrrolinodoxorubicin (AN-201) linked to octapeptide SRIF carrier RC-121, may overcome this resis

233 ral CCK receptor agonist CCK8S (sulfated CCK octapeptide) strongly depolarized the neurons, and this

234 CoA analogue [S-(2-oxo)pentadecylCoA] and an octapeptide substrate (GLYASKLA) to 2.5 A resolution.

235 A fluorescence-quenched octapeptide substrate based on the initial hemoglobin cl

236 those functional groups in the high-affinity octapeptide substrate GLYASKLS-NH2 1a necessary for tigh

237 nhibitors of Candida NMT with respect to the octapeptide substrate GNAASARR-NH2 with Ki(app) = 30 and

238 Binding of an octapeptide substrate, representing the N-terminal seque

239 anti-apoptotic effect of MN10021 and derived octapeptides suggesting that their potent vasoprotective

240 Either a hexahistidine or a FLAG octapeptide tag was incorporated into the FAS at either

241 Transframe octapeptide (TFP) Phe-Leu-Arg-Glu-Asp-Leu-Ala-Phe, the N

242 with a paired-type homeobox, as well as the octapeptide that is found in many paired-type homeobox g

243 In contrast to the peptide agonist CCK octapeptide, the functional activities of the nonpeptide

244 cently we demonstrated that the fusion of an octapeptide to the C-terminus of a cysteine-free mutant

245 significantly better in the cholecystokinin octapeptide-treated animals when compared to the control

246 Peptide T is an octapeptide under investigation for treatment of ADC pat

247 Octapeptide VDYNFTIV sensitized target cells for lysis b

248 ommon ligand, the vesicular stomatitis virus octapeptide (VSV8) bound to H-2Kb, were studied to defin

249 specific for the vesicular stomatitis virus octapeptide (VSV8) bound to K(b).

250 heat capacity change (DeltaCp) for the 5HT2c octapeptide was determined to be -94 cal/mol, and a calc

251 dder emptying in response to cholecystokinin octapeptide was measured gravimetrically.

252 ximal contraction induced by cholecystokinin octapeptide was significantly less in gallbladders with

253 -to-left synthetic approach to this bicyclic octapeptide was unsuccessful due to an inability to elab

254 ) and several lanthionine hexa-, hepta-, and octapeptides was carried out by using the method of cycl

255 nodoxorubicin (AN-201) linked to SST carrier octapeptide, was investigated in human renal cell carcin

256 sed approach and starting from a linear MLL1 octapeptide, we have designed a class of potent macrocyc

257 te formation induced by the full agonist CCK octapeptide were comparable for the wild-type receptor a

258 n response to 30 and 60 pmol cholecystokinin octapeptide were significantly lower in STZ-D rats compa

259 Pax-B contains both the homeodomain and the octapeptide, whereas hydra Pax-A contains neither.

260 The lanthionine octapeptide with C-terminal Thr-ol (1) showed similar hi

261 Similarly, the lanthionine octapeptide with the C-terminal Thr-NH2 residue (2) has

262 The design was partially based on an octapeptide with the same sequence as residues 11-18 abo

263 re the reaction of the antibodies with every octapeptide within MSP-1(42).

264 PLC) analysis of a tryptic digest yielded an octapeptide within the insert of PDE3A ((K)T(806)YNVTDDK

265 The octapeptide WRWYCRCK, containing amino acids from both h